United Therapeutics Corporation Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- United Therapeutics Corporation treasury stock, shares, acquired for the quarter ending 2013-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- United Therapeutics Corporation treasury stock, shares, acquired for the quarter ending 2013-06-30 was 609.90K shares.
- United Therapeutics Corporation treasury stock, shares, acquired for the quarter ending 2013-03-31 was 99.10K shares.
- United Therapeutics Corporation treasury stock, shares, acquired for the quarter ending 2012-09-30 was 788.29K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | |
| 2013-06-30 | 609.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | |
| 2013-03-31 | 99.10K shares 10-Q · filed 2013-04-25 | |
| 2012-09-30 | 788.29K shares 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |